Yang Y - Search Results

1

Clinicopathological characteristics, diagnosis, and prognosis of pregnancy-associated breast cancer.

Wang B, Yang Y, Jiang Z, Zhao J, Mao Y, Liu J, Zhang J. Wang B, et al. Among authors: yang y. Thorac Cancer. 2019 May;10(5):1060-1068. doi: 10.1111/1759-7714.13045. Epub 2019 Mar 28. Thorac Cancer. 2019. PMID: 30920126 Free PMC article.

2

[Significance of TIMP-1 and nm-23 expressions in HER-2-positive breast cancer].

Liu J, Yang YF, Fu XL, Yu Y, Gu L. Liu J, et al. Among authors: yang yf. Zhonghua Zhong Liu Za Zhi. 2012 Aug;34(8):600-4. doi: 10.3760/cma.j.issn.0253-3766.2012.08.009. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 23158994 Chinese.

3

[Clinical features and prognosis of 25 cases of breast carcinosarcoma].

Yang YF, Liu J, Fang ZY, Gu L. Yang YF, et al. Zhonghua Zhong Liu Za Zhi. 2012 Aug;34(8):620-3. doi: 10.3760/cma.j.issn.0253-3766.2012.08.014. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 23158999 Chinese.

4

[Application of pedicle fat flap for defect repair in breast-conserving surgery of breast cancer].

Liu J, Lin J, Hao YT, Yang YF, Fang ZY, Gu L. Liu J, et al. Zhonghua Yi Xue Za Zhi. 2012 Dec 25;92(48):3420-2. Zhonghua Yi Xue Za Zhi. 2012. PMID: 23327703 Chinese.

5

[Clinical characteristics and survival analysis of 22 cases of pure epithelial breast metaplastic carcinoma].

Meng HM, Yang YF, Qi LQ, Gu L. Meng HM, et al. Zhonghua Zhong Liu Za Zhi. 2013 Jul;35(7):525-9. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 24257306 Chinese.

6

[Efficacy of lapatinib versus trastuzumab in neoadjuvant therapy of HER-2 positive breast cancer: a meta-analysis].

Jiang Z, Yang Y, Pan Z, Yue Z, Li L. Jiang Z, et al. Among authors: yang y. Zhonghua Yi Xue Za Zhi. 2014 Dec 30;94(48):3854-8. Zhonghua Yi Xue Za Zhi. 2014. PMID: 25623322 Chinese.

7

[Clinical characteristics and prognosis in 20 patients with spindle cell carcinoma of the breast].

Liang Y, Zhang L, Yang Y, Liu J, Gu L. Liang Y, et al. Among authors: yang y. Zhonghua Zhong Liu Za Zhi. 2015 Jan;37(1):37-40. Zhonghua Zhong Liu Za Zhi. 2015. PMID: 25877317 Chinese.

8

Expression of STIM1 is associated with tumor aggressiveness and poor prognosis in breast cancer.

Yang Y, Jiang Z, Wang B, Chang L, Liu J, Zhang L, Gu L. Yang Y, et al. Pathol Res Pract. 2017 Sep;213(9):1043-1047. doi: 10.1016/j.prp.2017.08.006. Epub 2017 Aug 25. Pathol Res Pract. 2017. PMID: 28869106

9

Ginsenoside Rg3 attenuates cisplatin resistance in lung cancer by downregulating PD-L1 and resuming immune.

Jiang Z, Yang Y, Yang Y, Zhang Y, Yue Z, Pan Z, Ren X. Jiang Z, et al. Among authors: yang y. Biomed Pharmacother. 2017 Dec;96:378-383. doi: 10.1016/j.biopha.2017.09.129. Epub 2017 Oct 12. Biomed Pharmacother. 2017. PMID: 29031195

10

MicroRNA-223 Targeting STIM1 Inhibits the Biological Behavior of Breast Cancer.

Yang Y, Jiang Z, Ma N, Wang B, Liu J, Zhang L, Gu L. Yang Y, et al. Cell Physiol Biochem. 2018;45(2):856-866. doi: 10.1159/000487180. Epub 2018 Jan 31. Cell Physiol Biochem. 2018. PMID: 29414804 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110,518 results

Search Page

Filters